Loading…
BioLife Solutions, Inc. is projected to rise to $41.49 by 2027, a +33% move from its current price of $31.28. BLFS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $30.53 | $31.29 | $32.08 | +0.05% |
| Aug 3 | $30.23 | $31.31 | $32.43 | +0.09% |
| Aug 4 | $30.00 | $31.32 | $32.70 | +0.14% |
| Aug 5 | $29.82 | $31.34 | $32.94 | +0.18% |
| Aug 6 | $29.66 | $31.35 | $33.15 | +0.23% |
| Aug 7 | $29.51 | $31.37 | $33.34 | +0.28% |
| Aug 8 | $29.38 | $31.38 | $33.52 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $29.38 | $31.38 | $33.52 | +0.32% |
| Week 2 | $28.68 | $31.48 | $34.55 | +0.65% |
| Week 3 | $28.18 | $31.58 | $35.40 | +0.97% |
| Week 4 | $27.78 | $31.69 | $36.15 | +1.30% |
| Week 5 | $27.44 | $31.79 | $36.83 | +1.63% |
| Week 6 | $27.14 | $31.89 | $37.47 | +1.96% |
| Week 7 | $26.88 | $32.00 | $38.08 | +2.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.
It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors.
The company was incorporated in 1987 and is headquartered in Bothell, Washington.
BioLife Solutions, Inc. (BLFS) trades at $30.26 per share and has a market capitalization of $1.48B. It ranks 2232 in market capitalization among listed assets.
The forecast outlines a bullish long-run path, with a 2026 average price of $30.26 and a projected rise to higher levels in later years. The outlook becomes increasingly bullish from 2027 onward, with notable growth in average prices through 2050.
A major floor 40.6% below — a decisive break under it would weaken the trend.
The nearest floor, 20.7% below — buyers have tended to step in here.
Price is pressing into resistance (2.2% away) — a breakout level to watch.
A major ceiling 16.8% above — clearing it would confirm fresh momentum.
Key BLFS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BLFS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $31.24 | Buy | $31.21 | Buy |
| MA 10 | $30.64 | Buy | $30.70 | Buy |
| MA 20 | $29.55 | Buy | $29.78 | Buy |
| MA 50 | $27.60 | Buy | $27.67 | Buy |
| MA 100 | $24.02 | Buy | $25.84 | Buy |
| MA 200 | $24.40 | Buy | $24.77 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.47 | Neutral |
| Stoch RSI (14) | 33.73 | Neutral |
| CCI (20) | 93.01 | Neutral |
| Williams %R (14) | -21.02 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 7.31 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 78.98 | Neutral |
| TRIX (15) | 0.57 | Buy |
| Awesome (5,34) | 2.82 | Buy |
| Ultimate (7,14,28) | 58.03 | Neutral |
| Momentum (10) | 2.13 | Buy |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 31.88 | Sell |
| ADX (14) | 24.98 | Buy |
| ATR (14) | 0.64 | Info |
Technical snapshot for the last 30 days shows a bullish tilt. RSI (14) is 70, indicating strong recent momentum.
The 50-day simple moving average (SMA50) is $25.68, above the 200-day simple moving average (SMA200) of $24.17, signaling an uptrend. The immediate support level is $24.79 and the resistance is $30.26. The 30-day price range runs from $26.06 to $35.14, reflecting a broad move within that window.
Annualized volatility stands around 40% as a measure of price variability over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.15 | $31.28 | $43.65 | 0% | Neutral | |
| $33.36 | $41.49 | $54.39 | +33% | Bullish | |
| $39.49 | $50.39 | $68.39 | +61% | Bullish | |
| $54.18 | $70.59 | $98.44 | +126% | Bullish | |
| $64.04 | $85.00 | $121.26 | +172% | Bullish | |
| $74.76 | $100.91 | $146.83 | +223% | Bullish | |
| $84.71 | $116.13 | $172.03 | +271% | Bullish | |
| $86.13 | $119.81 | $180.35 | +283% | Bullish | |
| $100.94 | $142.36 | $217.50 | +355% | Bullish | |
| $116.78 | $166.88 | $258.52 | +434% | Bullish | |
| $194.62 | $295.17 | $484.51 | +844% | Bullish | |
| $429.81 | $721.29 | $1,288.63 | +22.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $18.15 | $31.28 | $38.87 | +0.00% |
| September 2026 | $27.70 | $32.68 | $39.60 | +4.49% |
| October 2026 | $27.48 | $32.62 | $39.92 | -0.18% |
| November 2026 | $28.41 | $33.90 | $41.81 | +3.91% |
| December 2026 | $29.32 | $35.15 | $43.65 | +3.68% |
Click any year to see its month-by-month BLFS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
BioLife Solutions, Inc.'s 2026 outlook centres on $31.28, within a $18.15 to $43.65 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, BLFS could reach as high as $54.39, with a base case around $41.49 and support toward $33.36 — roughly +33% from $31.28. Buyers look set to stay in control over this stretch.
Expect BLFS to range from $39.49 to $68.39 through 2028. The $50.39 average target implies a +61% move from current prices. That is up +21% on the projected 2027 average. Momentum favours further upside here.
The BLFS price prediction for 2029 points to an average of $70.59 (low $54.18, high $98.44) — a potential gain of +126% on today's $31.28. Buyers look set to stay in control over this stretch.
In 2030, BLFS is projected to trade between $64.04 and $121.26, averaging $85.00 — a potential gain of +172% from today's $31.28. That is up +20% on the projected 2029 average. Momentum favours further upside here.
BioLife Solutions, Inc.'s 2031 outlook centres on $100.91, within a $74.76 to $146.83 range. That is up +19% on the projected 2030 average. That marks a +223% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, BLFS could reach as high as $172.03, with a base case around $116.13 and support toward $84.71 — roughly +271% from $31.28. Momentum favours further upside here.
Expect BLFS to range from $86.13 to $180.35 through 2033. The $119.81 average target implies a +283% move from current prices. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The BLFS price prediction for 2034 points to an average of $142.36 (low $100.94, high $217.50) — a potential gain of +355% on today's $31.28. Momentum favours further upside here.
In 2035, BLFS is projected to trade between $116.78 and $258.52, averaging $166.88 — a potential gain of +434% from today's $31.28. That is up +17% on the projected 2034 average. Buyers look set to stay in control over this stretch.
BioLife Solutions, Inc.'s 2040 outlook centres on $295.17, within a $194.62 to $484.51 range. That is up +77% on the projected 2035 average. That marks a +844% change versus current levels. Momentum favours further upside here.
By 2050, BLFS could reach as high as $1,288.63, with a base case around $721.29 and support toward $429.81 — roughly +22.1x from $31.28. Buyers look set to stay in control over this stretch.
Investing $1,000 in BLFS today (≈ 31.969309 BLFS) could be worth
$23,059.25
+$22,059.25 (+2206%) by 2050 · US Dollar
Based on the average projected BLFS price of $721.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BLFSwould be worth at today's price.
$1,000 invested in BLFS on Jul 31, 2025 (≈ 47.036688 BLFS) would be worth
$1,471.31
+$471.31 (+47.1%) today · 1.47× · US Dollar
Based on a BLFS entry price of $21.26 vs. today's $31.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $29.98 | $1,043.36 | +4.3% |
| 1 month ago | $28.49 | $1,097.93 | +9.8% |
| 3 months ago | $21.21 | $1,474.78 | +47.5% |
| 6 months ago | $22.33 | $1,400.81 | +40.1% |
| 1 year ago | $21.26 | $1,471.31 | +47.1% |
| All time (5.0y) ago | $48.66 | $642.83 | -35.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BLFS forecast.
Our base-case forecast reaches $63.00 around 2029.
Implied market cap at $63.00: $3.08B
The multi-year forecast shows a steadily bullish trajectory with the following key levels:
- 2026: Avg $30.26, ROI 0, sentiment NEUTRAL (min $18.15, max $42.04)
- 2027: Avg $40.30, ROI 33.2, sentiment BULLISH
- 2028: Avg $49.53, ROI 63.7, sentiment BULLISH
- 2029: Avg $67.42, ROI 122.8, sentiment BULLISH
- 2030: Avg $81.59, ROI 169.6, sentiment BULLISH
- 2031: Avg $96.97, ROI 220.4, sentiment BULLISH
- 2032: Avg $109.79, ROI 262.8, sentiment BULLISH
- 2033: Avg $115.52, ROI 281.8, sentiment BULLISH
- 2034: Avg $138.35, ROI 357.2, sentiment BULLISH
- 2035: Avg $158.25, ROI 423, sentiment BULLISH
- 2040: Avg $283.23, ROI 836, sentiment BULLISH
- 2050: Avg $672.55, ROI 2122.6, sentiment BULLISH
These are estimates and not guarantees. The trend remains bullish across the long horizon, with higher average prices and escalating ROIs in later years.
Tap a question to reveal the answer.
2030 Avg $81.59, Min $62.27, Max $114.56, ROI 169.6%, sentiment BULLISH.
The forecast shows a bullish sentiment from 2027 onward with rising average prices and ROIs; 2026 is NEUTRAL. These are estimates, not guarantees.
Yes. The forecast lists a 2030 Min of $62.27, and a 2029 Max of $92.71, indicating prices above $60 appear in the forecast.
Current price is $30.26 and market capitalization is $1.48B.
Sentiment is BULLISH; RSI(14) is 70. SMA50 is $25.68 and SMA200 is $24.17. Support is $24.79 and resistance is $30.26. The 30-day range is $26.06 to $35.14.
BioLife Solutions, Inc. Community Discussion
0Share your BioLife Solutions, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.